Indaptus Historical Cash Flow
| INDP Stock | USD 7.30 0.86 10.54% |
Analysis of Indaptus Therapeutics cash flow over time is an excellent tool to project Indaptus Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 698 or Other Non Cash Items of 372.6 K as it is a great indicator of Indaptus Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Indaptus Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Indaptus Therapeutics is a good buy for the upcoming year.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. About Indaptus Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Indaptus balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Indaptus's non-liquid assets can be easily converted into cash.
Indaptus Therapeutics Cash Flow Chart
Add Fundamental
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Most accounts from Indaptus Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Indaptus Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Indaptus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. To learn how to invest in Indaptus Stock, please use our How to Invest in Indaptus Therapeutics guide.At this time, Indaptus Therapeutics' Change In Working Capital is relatively stable compared to the past year. As of 08/01/2025, Total Cashflows From Investing Activities is likely to grow to about 20.7 M, while Depreciation is likely to drop 698.25.
| 2022 | 2023 | 2024 | 2025 (projected) | Begin Period Cash Flow | 39.1M | 9.6M | 13.4M | 15.2M | End Period Cash Flow | 9.6M | 13.4M | 5.8M | 5.5M |
Indaptus Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
Indaptus Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Indaptus Therapeutics cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Free Cash Flow | (3.3M) | (11.3M) | (13.3M) | (13.4M) | (12.3M) | (12.9M) | |
| Change In Working Capital | 118.7K | (5.1M) | (1.6M) | (518.1K) | 392.3K | 411.9K | |
| Other Cashflows From Financing Activities | 1.2M | 43.3M | (16.4M) | 17.1M | (762.7K) | (724.6K) | |
| Depreciation | 852.0 | 1.4K | 1.8K | 1.3K | 735.0 | 698.25 | |
| Other Non Cash Items | (3.4M) | 5.7M | (134.2K) | (431.0K) | 392.3K | 372.6K | |
| Capital Expenditures | 9.6M | 921K | 3.9K | 172.6K | 5.0 | 0.0 | |
| Total Cash From Operating Activities | (3.3M) | (11.3M) | (13.1M) | (13.4M) | (12.3M) | (12.9M) | |
| Net Income | (3.6M) | (7.7M) | (14.3M) | (15.4M) | (15.0M) | (15.8M) | |
| Total Cash From Financing Activities | 1.2M | 48.3M | 363.1K | 0.0 | 4.7M | 4.5M | |
| End Period Cash Flow | 1.6M | 39.1M | 9.6M | 13.4M | 5.8M | 5.5M | |
| Begin Period Cash Flow | 3.8M | 1.6M | 39.1M | 9.6M | 13.4M | 15.2M | |
| Change In Cash | (2.2M) | 37.5M | (29.5M) | 3.7M | (7.6M) | (7.2M) | |
| Stock Based Compensation | 140.0K | 1.5M | 3.0M | 3.0M | 2.3M | 1.8M |
Additional Tools for Indaptus Stock Analysis
When running Indaptus Therapeutics' price analysis, check to measure Indaptus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Indaptus Therapeutics is operating at the current time. Most of Indaptus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Indaptus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Indaptus Therapeutics' price. Additionally, you may evaluate how the addition of Indaptus Therapeutics to your portfolios can decrease your overall portfolio volatility.